Back to Clearbridge Investments, LLC Clearbridge Investments, LLC

PTGXPTGX
3 quarters

Position history for Clearbridge Investments, LLCClearbridge Investments, LLC's holdings in PROTAGONIST THERAPEUTICS INC

Clearbridge Investments, LLC holds 725,335 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $88.9M as of 2026-Q2. The position was increased (+16.6% shares). PTGX represents 0.1% of Clearbridge Investments, LLC's portfolio.

Current Value

$88.9M

Current Shares

725,335

Total Value Change

+$46.1M

Total Shares Change

+235,493

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
725,335
+16.6%
$88.9M0.1%$122.58
35
2026-Q1
Increased
621,820
+26.9%
$65.5M0.1%$91.30
37
2025-Q4
New
489,842
-
$42.8M0.0%$87.26
40

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used